Healthcare -
Drug Manufacturers - Specialty & Generic - NYSE - US
$ 6.83
-8.69 %
$ 370 M
Market Cap
-1.75
P/E
EBS - ACCOUNTS PAYABLE
Accounts Payable EBS - Emergent BioSolutions Inc.
112 M
LAST VALUE
-6.70%
2 YEAR CAGR
6.81%
5 YEAR CAGR
15.09%
10 YEAR CAGR